A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest

Cellular Microbiology

Volumn 14, Issue 11, 2012, Pages 1745-1756

  Wei, Wei ^a   Guo, Haoran ^a   Han, Xue ^a   Liu, Xianjun ^a   Zhou, Xiaohong ^a,b   Zhang, Wenyan ^a   Yu, Xiao Fang ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BINDING PROTEIN; CELL PROTEIN; MUTANT PROTEIN; PROTEIN DCAF1; PROTEIN DDB1; PROTEIN SAMHD1; PROTEIN VPX; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL STRAIN HEK293; CONTROLLED STUDY; DENDRITIC CELL; DNA CONTENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; MACROPHAGE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; VIRION; VIRUS PARTICLE; VIRUS REPLICATION;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CARRIER PROTEINS; CELL CYCLE; CELL LINE; CONSERVED SEQUENCE; GENE PRODUCTS, VPR; HUMANS; MONOMERIC GTP-BINDING PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84867629398     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2012.01835.x     Document Type: Article

References (43)

1. Accola, M.A., Bukovsky, A.A., Jones, M.S., and Gottlinger, H.G. (1999) A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm). J Virol 73: 9992-9999.
2. Ahn, J., Hao, C., Yan, J., DeLucia, M., Mehrens, J., Wang, C., etal. (2012) HIV/simian immunodeficiency virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1. J Biol Chem 287: 12550-12558.
3. Battey, J.N., Kopp, J., Bordoli, L., Read, R.J., Clarke, N.D., and Schwede, T. (2007) Automated server predictions in CASP7. Proteins 69 (Suppl. 8): 68-82.
4. Belzile, J.P., Duisit, G., Rougeau, N., Mercier, J., Finzi, A., and Cohen, E.A. (2007) HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 3: e85.
5. Bergamaschi, A., Ayinde, D., David, A., Le Rouzic, E., Morel, M., Collin, G., etal. (2009) The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J Virol 83: 4854-4860.
6. Berger, A., Munk, C., Schweizer, M., Cichutek, K., Schule, S., and Flory, E. (2010) Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. J Biol Chem 285: 12248-12254.
7. Berger, A., Sommer, A.F., Zwarg, J., Hamdorf, M., Welzel, K., Esly, N., etal. (2011) SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog 7: e1002425.
8. DeHart, J.L., Zimmerman, E.S., Ardon, O., Monteiro-Filho, C.M., Arganaraz, E.R., and Planelles, V. (2007) HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virol J 4: 57.
9. Fujita, M., Otsuka, M., Miyoshi, M., Khamsri, B., Nomaguchi, M., and Adachi, A. (2008) Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages. J Virol 82: 7752-7756.
10. Gibbs, J.S., Lackner, A.A., Lang, S.M., Simon, M.A., Sehgal, P.K., Daniel, M.D., and Desrosiers, R.C. (1995) Progression to AIDS in the absence of a gene for vpr or vpx. J Virol 69: 2378-2383.
11. Goujon, C., Riviere, L., Jarrosson-Wuilleme, L., Bernaud, J., Rigal, D., Darlix, J.L., and Cimarelli, A. (2007) SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 4: 2.
12. Gramberg, T., Sunseri, N., and Landau, N.R. (2010) Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J Virol 84: 1387-1396.
13. Guyader, M., Emerman, M., Montagnier, L., and Peden, K. (1989) VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J 8: 1169-1175.
14. He, Z., Zhang, W., Chen, G., Xu, R., and Yu, X.F. (2008) Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J Mol Biol 381: 1000-1011.
15. Henderson, L.E., Sowder, R.C., Copeland, T.D., Benveniste, R.E., and Oroszlan, S. (1988) Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science 241: 199-201.
16. Hirsch, V.M., Sharkey, M.E., Brown, C.R., Brichacek, B., Goldstein, S., Wakefield, J., etal. (1998) Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med 4: 1401-1408.
17. Hrecka, K., Gierszewska, M., Srivastava, S., Kozaczkiewicz, L., Swanson, S.K., Florens, L., etal. (2007) Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci USA 104: 11778-11783.
18. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S.K., Kesik-Brodacka, M., Srivastava, S., etal. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
19. Kappes, J.C., Conway, J.A., Lee, S.W., Shaw, G.M., and Hahn, B.H. (1991) Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Virology 184: 197-209.
20. Kaushik, R., Zhu, X., Stranska, R., Wu, Y., and Stevenson, M. (2009) A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 6: 68-80.
21. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., etal. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
22. Laguette, N., Rahm, N., Sobhian, B., Chable-Bessia, C., Munch, J., Snoeck, J., etal. (2012) Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11: 205-217.
23. Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E.C., Dragin, L., etal. (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13: 223-228.
24. Le Rouzic, E., Belaidouni, N., Estrabaud, E., Morel, M., Rain, J.C., Transy, C., and Margottin-Goguet, F. (2007) HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6: 182-188.
25. Lim, E.S., Fregoso, O.I., McCoy, C.O., Matsen, F.A., Malik, H.S., and Emerman, M. (2012) The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11: 194-204.
26. McCall, C.M., Miliani de Marval, P.L., Chastain, P.D., 2nd, Jackson, S.C., He, Y.J., Kotake, Y., etal. (2008) Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development. Mol Cell Biol 28: 5621-5633.
27. Mangeot, P.E., Duperrier, K., Negre, D., Boson, B., Rigal, D., Cosset, F.L., and Darlix, J.L. (2002) High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 5: 283-290.
28. Marcon, L., Michaels, F., Hattori, N., Fargnoli, K., Gallo, R.C., and Franchini, G. (1991) Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication. J Virol 65: 3938-3942.
29. Morellet, N., Bouaziz, S., Petitjean, P., and Roques, B.P. (2003) NMR structure of the HIV-1 regulatory protein VPR. J Mol Biol 327: 215-227.
30. Paxton, W., Connor, R.I., and Landau, N.R. (1993) Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol 67: 7229-7237.
31. Pertel, T., Reinhard, C., and Luban, J. (2011) Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology 8: 49.
32. Rice, G.I., Bond, J., Asipu, A., Brunette, R.L., Manfield, I.W., Carr, I.M., etal. (2009) Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41: 829-832.
33. Schrofelbauer, B., Hakata, Y., and Landau, N.R. (2007) HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc Natl Acad Sci USA 104: 4130-4135.
34. Schuler, W., Wecker, K., de Rocquigny, H., Baudat, Y., Sire, J., and Roques, B.P. (1999) NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions. J Mol Biol 285: 2105-2117.
35. Selig, L., Pages, J.C., Tanchou, V., Preveral, S., Berlioz-Torrent, C., Liu, L.X., etal. (1999) Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J Virol 73: 592-600.
36. Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M., and Stevenson, M. (2008) Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 4: e1000057.
37. Srivastava, S., Swanson, S.K., Manel, N., Florens, L., Washburn, M.P., and Skowronski, J. (2008) Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog 4: e1000059.
38. Stanley, B.J., Ehrlich, E.S., Short, L., Yu, Y., Xiao, Z., Yu, X.F., and Xiong, Y. (2008) Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J Virol 82: 8656-8663.
39. Wen, X., Duus, K.M., Friedrich, T.D., and de Noronha, C.M. (2007) The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor. J Biol Chem 282: 27046-27057.
40. Wu, X., Conway, J.A., Kim, J., and Kappes, J.C. (1994) Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J Virol 68: 6161-6169.
41. Yu, X.F., Ito, S., Essex, M., and Lee, T.H. (1988) A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature 335: 262-265.
42. Yu, X.F., Yu, Q.C., Essex, M., and Lee, T.H. (1991) The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage. J Virol 65: 5088-5091.
43. Zhang, C., de Silva, S., Wang, J.H., and Wu, L. (2012) Co-Evolution of Primate SAMHD1 and Lentivirus Vpx Leads to the Loss of the vpx Gene in HIV-1 Ancestor. PLoS ONE 7: e37477.